Latest pharmaceutical drug prices and trends for NDC 58151-0240

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
LYRICA 150 MG CAPSULE	58151-0240-88	9.69430	EACH	2025-04-23
LYRICA 150 MG CAPSULE	58151-0240-32	9.69430	EACH	2025-04-23
LYRICA 150 MG CAPSULE	58151-0240-77	9.69430	EACH	2025-04-23
LYRICA 150 MG CAPSULE	58151-0240-32	9.68883	EACH	2025-03-19
LYRICA 150 MG CAPSULE	58151-0240-77	9.68883	EACH	2025-03-19
LYRICA 150 MG CAPSULE	58151-0240-88	9.68883	EACH	2025-03-19
LYRICA 150 MG CAPSULE	58151-0240-77	9.68547	EACH	2025-02-12
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Subscribe to access the full database, or Try for Free

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

The pharmaceutical industry is constantly evolving, with drug prices and market dynamics playing crucial roles in shaping healthcare costs and patient access to medications. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug with National Drug Code (NDC) 58151-0240, exploring its current position and future outlook in the pharmaceutical landscape.

Understanding NDC 58151-0240

Before we dive into the market analysis, it's essential to understand what NDC 58151-0240 represents. The National Drug Code is a unique, three-segment number assigned by the U.S. Food and Drug Administration (FDA) to human drugs in the United States. It serves as a universal product identifier for drugs[7].

Decoding the NDC

The NDC 58151-0240 can be broken down as follows:

Labeler Code: 58151
Product Code: 024
Package Code: 0

This specific NDC belongs to a drug manufactured or distributed by a company with the FDA-assigned labeler code 58151. The product code 024 identifies the specific strength, dosage form, and formulation of the drug, while the package code 0 indicates its package size and type.

Current Market Position

To understand the market position of NDC 58151-0240, we need to consider various factors, including its therapeutic category, competition, and current pricing.

Therapeutic Category and Indications

While the search results don't provide specific information about the therapeutic category of NDC 58151-0240, understanding a drug's indications is crucial for assessing its market potential. Different therapeutic areas have varying levels of competition and market dynamics.

Competitive Landscape

The competitive landscape for NDC 58151-0240 would depend on factors such as:

Number of similar drugs in the same therapeutic class
Presence of generic alternatives
Patent status
Unique features or benefits of the drug

Current Pricing Strategy

Drug pricing is a complex issue influenced by various factors. For NDC 58151-0240, we would need to consider:

List price
Net price after rebates and discounts
Pricing relative to competitors
Reimbursement rates by insurance companies and government programs

Market Trends Affecting Drug Pricing

Several overarching trends in the pharmaceutical industry are likely to impact the pricing and market position of NDC 58151-0240.

Overall Drug Price Inflation

According to Vizient's summer Pharmacy Market Outlook, the projected overall drug price inflation rate for pharmaceuticals in 2025 is estimated at 3.81%[2]. This projection takes into account factors such as:

Expanding indications for previously approved medications
Introduction of new high-cost therapies
Market dynamics and competition

Vizient, Inc. released its summer Pharmacy Market Outlook estimating the 2025 overall drug price inflation rate for pharmaceuticals at 3.81%[2].

Impact of Non-Traditional Models

The emergence of non-traditional pharmaceutical companies is introducing new dynamics to the market. A study by the Office of the Assistant Secretary for Planning and Evaluation (ASPE) found that:

Non-traditional models can produce drug volumes equal to or larger than traditional competitors
Pricing strategies of non-traditional models vary, with some offering lower prices than traditional competitors[3]

This trend could potentially impact the pricing and market share of drugs like NDC 58151-0240, depending on its therapeutic category and market position.

Drug Shortages and Essential Medicines

The ASPE study also highlighted the role of non-traditional models in addressing drug shortages and producing essential medicines:

44% of drugs in the study sample experienced shortages at some point
Non-traditional models showed increased production of essential medicines over time[3]

If NDC 58151-0240 falls into the category of essential medicines or has experienced shortages, these factors could significantly influence its market dynamics and pricing.

Factors Influencing Future Price Projections

Several key factors will likely influence the future pricing of NDC 58151-0240:

1. Patent Status and Generic Competition

The patent status of NDC 58151-0240 will play a crucial role in its future pricing. If the drug is nearing patent expiration, the potential entry of generic competitors could exert downward pressure on prices.

2. Regulatory Environment

Changes in drug pricing regulations and policies can significantly impact pharmaceutical prices. Recent and upcoming policy changes to monitor include:

Medicare drug price negotiation provisions
Inflation rebate programs
Out-of-pocket cost caps for Medicare beneficiaries

3. Market Demand and Therapeutic Advancements

The demand for NDC 58151-0240 will be influenced by factors such as:

Prevalence of the condition it treats
Emergence of new treatment options
Clinical guidelines and prescribing patterns

4. Manufacturing Costs and Supply Chain Dynamics

Changes in raw material costs, manufacturing processes, or supply chain disruptions can impact the production costs and, consequently, the pricing of NDC 58151-0240.

Price Projections for NDC 58151-0240

While specific price projections for NDC 58151-0240 are not available in the search results, we can make some informed estimates based on overall market trends and industry projections.

Short-term Outlook (1-2 years)

In the short term, the price of NDC 58151-0240 is likely to follow the overall pharmaceutical inflation rate of 3.81% projected by Vizient for 2025[2]. However, this could be higher or lower depending on factors specific to the drug, such as:

Competitive pressures
Changes in manufacturing costs
Shifts in demand or prescribing patterns

Medium-term Outlook (3-5 years)

The medium-term outlook for NDC 58151-0240 will depend largely on its patent status and the potential entry of generic competitors. If generics enter the market during this period, we could see a significant drop in price, potentially up to 80-90% for small molecule drugs.

Long-term Outlook (5+ years)

Long-term price projections are more uncertain and will be influenced by factors such as:

Technological advancements in drug manufacturing
Changes in the regulatory landscape
Shifts in healthcare delivery models
Potential disruptive innovations in the pharmaceutical industry

Strategies for Stakeholders

Various stakeholders in the healthcare ecosystem can take steps to navigate the evolving market dynamics surrounding NDC 58151-0240:

For Healthcare Providers

Stay informed about potential generic alternatives or therapeutic equivalents
Consider cost-effectiveness when making prescribing decisions
Engage in value-based care models that incentivize cost-effective treatments

For Payers

Implement formulary management strategies to encourage use of cost-effective alternatives
Negotiate contracts with manufacturers that include value-based pricing arrangements
Utilize data analytics to identify opportunities for cost savings

For Patients

Discuss potential lower-cost alternatives with healthcare providers
Utilize patient assistance programs or copay cards when available
Stay informed about insurance coverage and out-of-pocket costs

For Manufacturers

Invest in real-world evidence generation to demonstrate the value of NDC 58151-0240
Explore innovative pricing models, such as outcomes-based contracts
Continuously optimize manufacturing processes to maintain competitive pricing

The Role of Technology in Shaping Drug Pricing

Advancements in technology are playing an increasingly important role in drug pricing and market dynamics:

Artificial Intelligence and Machine Learning

AI and ML algorithms are being used to:

Optimize pricing strategies
Predict market trends and demand
Improve manufacturing efficiency

Blockchain Technology

Blockchain has the potential to:

Enhance supply chain transparency
Reduce counterfeit drugs
Streamline rebate processing

Big Data Analytics

Big data is enabling:

More accurate demand forecasting
Personalized medicine approaches
Real-time monitoring of drug utilization and outcomes

Global Market Considerations

While our focus has been on the U.S. market, it's important to consider global factors that could influence the pricing and market position of NDC 58151-0240:

International Reference Pricing

Many countries use international reference pricing, where drug prices are set based on prices in other countries. This practice can create a ripple effect on global drug pricing.

Parallel Trade

In some regions, particularly the European Union, parallel trade of pharmaceuticals can impact pricing strategies and market dynamics.

Emerging Markets

The growth of pharmaceutical markets in emerging economies can influence global pricing strategies and manufacturing decisions.

Ethical Considerations in Drug Pricing

As we analyze market trends and price projections, it's crucial to consider the ethical implications of drug pricing:

Balancing Innovation and Affordability

The pharmaceutical industry must strike a balance between incentivizing innovation through pricing and ensuring patient access to life-saving medications.

Transparency in Pricing

There's a growing demand for greater transparency in how drug prices are set, including disclosure of research and development costs, marketing expenses, and profit margins.

Equitable Access

Ensuring equitable access to essential medications, regardless of socioeconomic status or geographic location, remains a critical ethical consideration in drug pricing.

Key Takeaways

The pharmaceutical market is projected to see an overall drug price inflation rate of 3.81% in 2025, which could impact NDC 58151-0240.
Non-traditional pharmaceutical models are introducing new dynamics to the market, potentially affecting pricing and competition.
Future pricing of NDC 58151-0240 will be influenced by factors such as patent status, regulatory changes, market demand, and manufacturing costs.
Stakeholders across the healthcare ecosystem can employ various strategies to navigate the evolving market dynamics.
Technological advancements, global market considerations, and ethical implications play crucial roles in shaping drug pricing strategies.

FAQs

Q: How often are drug prices typically adjusted? A: Drug prices can be adjusted annually or more frequently, depending on market conditions, competition, and company policies. However, some manufacturers have pledged to limit price increases to once per year.
Q: Can patients negotiate drug prices? A: While individual patients typically can't negotiate drug prices directly, they can explore options such as patient assistance programs, copay cards, or discussing lower-cost alternatives with their healthcare providers.
Q: How do drug shortages affect pricing? A: Drug shortages can lead to price increases due to supply and demand dynamics. In some cases, they may also prompt the entry of new manufacturers or the use of alternative therapies, which can impact long-term pricing.
Q: What role do pharmacy benefit managers (PBMs) play in drug pricing? A: PBMs negotiate drug prices and rebates with manufacturers on behalf of insurers and employers. They play a significant role in determining which drugs are covered by insurance plans and at what cost to patients.
Q: How might future healthcare reforms impact drug pricing? A: Future healthcare reforms could potentially impact drug pricing through measures such as allowing Medicare to negotiate drug prices, implementing international reference pricing, or capping out-of-pocket costs for patients. The specific impact would depend on the details of any enacted reforms.

Sources cited: [2] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-drug-price-inflation [3] https://aspe.hhs.gov/sites/default/files/documents/172d065c60a40a7c77b3fb46eef0e4f4/sdp-nonprofit-quantitative-ib.pdf [7] https://www.fda.gov/drugs/development-approval-process-drugs/national-drug-code-database-background-information